Ethoxyphenyl thienyl compounds and methods for the treatment of bacterial infections

a technology of ethoxyphenyl thienyl and compounds, applied in the field of ethoxyphenyl thienyl compounds and methods for the treatment of bacterial infections, can solve the problems of association of utis in younger children with greater risk of morbidity and mortality

Active Publication Date: 2015-01-29
DUKE UNIV +2
View PDF1 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

UTIs in younger children are associated with greater risk of morbidity and mortality than in older children and adults.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Ethoxyphenyl thienyl compounds and methods for the treatment of
bacterial infections
  • Ethoxyphenyl thienyl compounds and methods for the treatment of
bacterial infections
  • Ethoxyphenyl thienyl compounds and methods for the treatment of
bacterial infections

Examples

Experimental program
Comparison scheme
Effect test

examples section 1

[0068]Introduction: Urinary tract infections are the second most common infection in humans, and the bacterium Escherichia coli accounts for >80% of the infections in the community and >50% of the nosocomial infections. Polysaccharide capsules are ubiquitous among these pathogenic strains and the mechanism of capsule biogenesis is different than that for the related commensal strains. Pathogenic E. coli causing urinary tract infections have surged in antibiotic resistance in the past decade, particularly for the most commonly used oral agents, thus necessitating the development of new targets and chemical probes against these targets to disable the organism during infection. This disclosure describes our novel development of a screening process to identify inhibitors of E. coli capsule biogenesis.

[0069]Materials and Methods

[0070]Overall Assay Strategy:

[0071]The ability of the T1 bacteriophage to bind to bacterial capsule, infect, and lyse E. coli UT189 was used as the primary assay ...

references example 3

8. REFERENCES EXAMPLE 3

[0297]1. NKUDIC (2005) Urinary Tract Infections in Adults.[0298]2. Schappert S, Rechtsteiner E (2011) Ambulatory medical care utilization estimates for 2007. Vital and health statistics. Series 13.[0299]3. Foxman B (2010) The epidemiology of urinary tract infection. Nat Rev Urol 7: 653-660. doi:10.1038 / nrurol.2010.190.[0300]4. Gupta K, Scholes D, Stamm W E (1999) Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. Jama 281: 736-738. doi:jbr80382 [pii].[0301]5. Ma J F, Shortliffe L M D (2004) Urinary tract infection in children: etiology and epidemiology. Urol Clin North Am 31: 517-26, ix-x. doi:10.1016 / j.uc1.2004.04.016.[0302]6. Hooton T M, Scholes D, Stapleton A E, Roberts P L, Winter C, et al. (2000) A prospective study of asymptomatic bacteriuria in sexually active young women. N Engl J Med 343: 992-997. doi:10.1056 / NEJM200010053431402.[0303]7. Foxman B, Brown P (2003) Epidemiology of urinary t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
pHaaaaaaaaaa
pHaaaaaaaaaa
pHaaaaaaaaaa
Login to view more

Abstract

This invention relates generally to the discovery of a method of inhibiting, preventing or treating bacterial infections. The invention also relates to a method of inhibiting bacterial capsule biogenesis.

Description

CROSS REFERENCE TO RELATED APPLICATIONS[0001]This application claims the benefit of U.S. application Ser. No. 14 / 305,649 filed Jun. 16, 2014 entitled “COMPOSITIONS AND METHODS FOR THE TREATMENT OF BACTERIAL INFECTIONS” having Atty. Dkt. No. 210 / 26 UTIL and U.S. Provisional Appn. 61 / 890,930, filed Oct. 15, 2013, entitled “COMPOSITIONS AND METHODS FOR THE TREATMENT OF BACTERIAL INFECTIONS” having Atty. Dkt. No. DU3745PROV which are hereby incorporated by reference in their entireties.STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT[0002]This invention was made with government support under Grant No. MH090791-02 awarded by the National Institutes of Health. The United States Government has certain rights in the invention.1. FIELD OF THE INVENTION[0003]This invention relates generally to the discovery of a method of inhibiting, preventing or treating bacterial infections. The invention also relates to a method of inhibiting bacterial capsule biogenesis.2. BACKGROUND OF TH...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): C07D333/24C07D409/12A61K31/545A61K31/381C12Q1/02A61K31/43
CPCC07D333/24C12Q1/025C07D409/12A61K31/545A61K31/381A61K31/43A61K31/4439C07D417/12Y02A50/30
Inventor SEED, PATRICK C.GOLLER, CARLOS C.DUTTA, APURBAMAKI, BROOKSSCHOENEN, FRANKNOAH, JAMESWHITE, LUCILE
Owner DUKE UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products